T cell engagers (TCE) such as chimeric antigen receptor (CAR) T cell therapy and bispecific
antibodies (BiAbs) for the treatment of multiple myeloma (MM) have significantly improved …

Certain drugs may increase the risk of ischemic stroke (IS). Our goal was to review
associations between frequently used drugs and IS. We created an initial list of frequently …

The scientific community rapidly responded to the COVID-19 pandemic by developing novel
SARS-CoV-2 vaccines (table 1). As of early June 2021, an estimated 2 billion doses have …

Background Immune thrombocytopenia (ITP) is a heterogeneous acquired disorder
characterized by isolated thrombocytopenia whose exact pathogenesis is not yet clear …

Systemic lupus erythematosus (SLE) is a chronic inflammatory disease with an unknown
etiology that can affect any organ or system of the human body. Hematological, renal, or …

Immune thrombocytopenia (ITP), previously called idiopathic thrombocytopenia purpura, is
an autoimmune disorder characterized by a severe reduction in peripheral blood platelet …

Objective To compare disease course in patients with Guillain-Barré syndrome (GBS) with a
poor prognosis who were treated with one or with two intravenous immunoglobulin (IVIg) …

Immune thrombocytopenia (ITP) is an autoimmune disease affecting blood platelets that
causes thrombocytopenia and an increased risk of bleeding. First-line therapy is indicated …

Objective: To evaluate intravenous immune globulin (IVIG) for autoimmune heparin-induced
thrombocytopenia (aHIT), including platelet recovery, IVIG dose, dosing weight, IVIG product …

Chronic inflammatory demyelinating polyneuropathy is a disabling but treatable disorder.
However, misdiagnosis is common, and it can be difficult to optimise its treatment. Various …